Bank of New York Mellon’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bank of New York Mellon’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Sell	5,251 -1	-0%	-$191	﹤0.01%	3109
2026 Q1	$872K	Hold	5,252	–	–	﹤0.01%	3289
2025 Q4	$837K	Hold	5,252	–	–	﹤0.01%	3336
2025 Q3	$492K	Sell	5,252 -7	-0.1%	-$495	﹤0.01%	3600
2025 Q2	$299K	Buy	5,259 +4	+0.1%	+$212	﹤0.01%	3804
2025 Q1	$320K	Sell	5,255 -47	-0.9%	-$4K	﹤0.01%	3672
2024 Q4	$477K	Buy	5,302 +51	+1%	+$6K	﹤0.01%	3554
2024 Q3	$676K	Sell	5,251 -1	-0%	-$130	﹤0.01%	3348
2024 Q2	$596K	Buy	+5,252	New	+$562K	﹤0.01%	3483
2022 Q4	–	Sell	-1,500	Closed	-$210K	–	4523
2022 Q3	$210K	Buy	+1,500	New	+$275K	﹤0.01%	3995

Other funds holding LABU

MIG

McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return

EFG

Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Simmons Bank Pine Bluff, Arkansas $1.75B AUM 33.61% 1-Year Est. Return

VPW

Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return

HHGA

Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Covestor London, United Kingdom $173M AUM 56.91% 1-Year Est. Return

Bank of New York Mellon's LABU Position: Q2 2026 in Review

Bank of New York Mellon reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 0.02% in Q2 2026, selling an estimated $191 and leaving 5,251 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3109.

Bank of New York Mellon first reported a position in LABU in Q3 2022 and has held it in 10 quarters since. 17 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

Bank of New York Mellon held 5,251 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $1.53M as of Q2 2026.
Bank of New York Mellon sold 1 Direxion Daily S&P Biotech Bull 3X ETF share in Q2 2026, an estimated $191.
Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3109 holding.
Bank of New York Mellon first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2022 and has held it in 10 quarters since.
17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.